[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us

NHS Litigation Authority

by Jackie (née Heneghan) Peck | Jun 12, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Regulation

The NHS Litigation Authority have recently published statistics on their website relating to appeals for pharmacy contracts. The number of appeals since the new market entry regulations has decreased however this may be a market anomaly as applicants get their heads...

Technology in Health and the emergence of Apple

by Jackie (née Heneghan) Peck | Jun 12, 2014 | Behind the scenes, Blog, Regulation

It was announced earlier this month that Apple were launching their own healthcare and fitness app called HealthKit.  The app is part of iOS8 and has the potential to communicate patient health data to hospitals and clinicians. The idea behind all of this is...

Online Pharmacy – are patients better with a ‘face to face’?

by Jackie (née Heneghan) Peck | Jun 12, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Regulation

Recent coverage in the Australian community pharmacy press has centred around the benefit and/or potential harm of prescribing and dispensing medicines without a face-to-face consultation.  The discussion raised asked the question whether an online questionnaire is...

RP & GDP Training for WDA(H)

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

RP – Responsible Person relating to MHRA GDP – Good Distribution Practice – the guidelines by which medicine wholesalers must adhere to WDA(H) – Wholesale Distribution Authorisation for Human Use – previously Wholesale Dealer’s...

Out of Specification (OOS) Test Results

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Pharmacy Suppliers, Regulation

What are Out of Specification results (OOS)?  It seems to be clear enough in the name but I thought I better check it out. One definition is: All test results which fall outside the specifications or acceptance criteria established in drug applications, drug master...

Quality Agreements- Technical Agreements- Good ones are invaluable!

by Jackie (née Heneghan) Peck | May 12, 2014 | Blog, Pharmacy Brands, Pharmacy Suppliers, Regulation

TAs – when do we need them in place and who with and what should be in them? PCL have been reviewing a few TAs over the last few weeks and we have put a few tips and hints together. If you only follow GDP or GMP; the principals are the same. If you are a...
« Older Entries
Next Entries »

Recent Posts

  • CPD Accreditation – Directory listing
  • Tobacco and Vapes Bill becomes law
  • Medicines Supply Shortages and the impact on pharmacies when Drug Tariff prices do not keep up with the cost of drugs

Upcoming Courses

  • Licence Holder Training on 3 August 2026 10:00 am
  • RP Forum – tbc on 4 August 2026 10:00 am
  • Superintendent Pharmacist training (Online) on 7 August 2026
  • GDP/RP Cogent Gold Standard Online Training on 18 August 2026
  • Introduction to Good Distribution Practice Online Training on 21 August 2026 10:00 am

MHRA Alerts & Recalls

Field Safety Notices: 29 June to 03 July 2026
29 July 2026
Field Safety Notices: 20 to 24 July 2026
28 July 2026
Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
23 July 2026
Field Safety Notices: 13 to 17 July 2026
21 July 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow